BACKGROUND
BioSight develops custom manufacturing services of peptides and combinatorial compounds for laboratories in the pharmaceutical industry and academic institutions. BioSight specializes in the production of high-quality peptides for standard and unique applications. The peptides are custom made to meet customers’ specific needs.

 

The Company is focused on developing unique peptide-based drug targeting and delivery systems for unmet clinical needs. Using its proprietary discoveries in the fields of functional combinatorial chemistry and peptide synthesis, BioSight is designing a number of pro-drug guided vectors that can target and release therapeutic drugs directly into the site of the disease, while significantly minimizing side effects, increasing selectivity, and expanding the therapeutic window.

 

Mark Gengrinovitch, CEO and Founder

Stela Gengrinovitch, Ph.D, C.S.O and Founder

Dr. Ehud Shoshani, VP Clinical Affairs

Ety Shaoul, D.Sc., R&D Manager

Esther Izakovich, Ph.D., Chemistry Manager

Felix Skorka, COO